Trials / Completed
CompletedNCT00321321
The Beta Cell Responsiveness to Glucose-dependent Insulinotropic Polypeptide (GIP) With and Without Sulfonylurea in Patients With Type 2 Diabetes
Phase 2 Study of The Beta Cell Responsiveness to GIP With and Without Sulfonylurea in Patients With Type 2 Diabetes
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- University Hospital, Gentofte, Copenhagen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators hypothesize that the impaired insulinotropic effect of the incretin hormone GIP may be due to inadequate sensitization and ATP induced closure of beta cell K-ATP channels. By closing the channels through the use of sulfonylurea (SU) we hope to restore the insulinotropic effect of GIP.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sulfonylurea |
Timeline
- Start date
- 2006-05-01
- Primary completion
- 2007-03-01
- Completion
- 2007-04-01
- First posted
- 2006-05-03
- Last updated
- 2015-07-16
- Results posted
- 2008-10-02
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00321321. Inclusion in this directory is not an endorsement.